These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34054689)

  • 21. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice.
    Watson G; Bastacky J; Belichenko P; Buddhikot M; Jungles S; Vellard M; Mobley WC; Kakkis E
    Gene Ther; 2006 Jun; 13(11):917-25. PubMed ID: 16482204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics identifies novel biomarkers of synovial joint disease in a canine model of mucopolysaccharidosis I.
    Zhang C; Gawri R; Lau YK; Spruce LA; Fazelinia H; Jiang Z; Jo SY; Scanzello CR; Mai W; Dodge GR; Casal ML; Smith LJ
    Mol Genet Metab; 2023 Feb; 138(2):107371. PubMed ID: 36709534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene.
    Hartung SD; Reddy RG; Whitley CB; McIvor RS
    Hum Gene Ther; 1999 Sep; 10(13):2163-72. PubMed ID: 10498248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.
    Wraith JE
    J Inherit Metab Dis; 2001 Apr; 24(2):245-50. PubMed ID: 11405343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I.
    Brooks DA
    Expert Opin Biol Ther; 2002 Dec; 2(8):967-76. PubMed ID: 12517274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells.
    Ngiwsara L; Ketudat-Cairns JR; Sawangareetrakul P; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Tim-Aroon T; Wattanasirichaigoon D; Svasti J
    Ann Hum Genet; 2018 May; 82(3):150-157. PubMed ID: 29282708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA.
    King B; Hassiotis S; Rozaklis T; Beard H; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM
    J Neurochem; 2016 May; 137(3):409-22. PubMed ID: 26762778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II.
    Wang J; Bhalla A; Ullman JC; Fang M; Ravi R; Arguello A; Thomsen E; Tsogtbaatar B; Guo JL; Skuja LL; Dugas JC; Davis SS; Poda SB; Gunasekaran K; Costanzo S; Sweeney ZK; Henry AG; Harris JM; Henne KR; Astarita G
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I).
    Barbosa Mendes A; do Nascimento CC; D'Almeida V
    PLoS One; 2019; 14(12):e0220429. PubMed ID: 31834922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel LC-MS/MS assay to quantify dermatan sulfate in cerebrospinal fluid as a biomarker for mucopolysaccharidosis II.
    Pan P; Chen M; Zhang Z; Corte AD; Souza C; Giugliani R; Pan L; Qiu Y; Amaravadi L; Wu J
    Bioanalysis; 2018 Jun; 10(11):825-838. PubMed ID: 29863901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
    Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
    J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-
    Song L; Bower JJ; Llanga T; Salmon JH; Hirsch ML; Gilger BC
    Mol Ther Methods Clin Dev; 2020 Sep; 18():24-32. PubMed ID: 32542182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.
    Provenzale JM; Nestrasil I; Chen S; Kan SH; Le SQ; Jens JK; Snella EM; Vondrak KN; Yee JK; Vite CH; Elashoff D; Duan L; Wang RY; Ellinwood NM; Guzman MA; Shapiro EG; Dickson PI
    Exp Neurol; 2015 Nov; 273():1-10. PubMed ID: 26222335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.
    Clarke LA; Giugliani R; Guffon N; Jones SA; Keenan HA; Munoz-Rojas MV; Okuyama T; Viskochil D; Whitley CB; Wijburg FA; Muenzer J
    Clin Genet; 2019 Oct; 96(4):281-289. PubMed ID: 31194252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs--a proof of principle study.
    Hemsley KM; Norman EJ; Crawley AC; Auclair D; King B; Fuller M; Lang DL; Dean CJ; Jolly RD; Hopwood JJ
    Mol Genet Metab; 2009 Dec; 98(4):383-92. PubMed ID: 19699666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
    Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
    Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucopolysaccharidosis type I: Identification and characterization of mutations affecting alpha-L-iduronidase activity.
    Lee-Chen GJ; Lin SP; Chen IS; Chang JH; Yang CW; Chin YW
    J Formos Med Assoc; 2002 Jun; 101(6):425-8. PubMed ID: 12189649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.